Diabetes and stress hyperglycemia were associated with worse clinical outcomes and mortality in patients with COVID-19. These patients should be identified early and considered them high risk at the COVID-19 diagnosis to mitigate adverse outcomes.
Keyphrases
- end stage renal disease
- coronavirus disease
- sars cov
- type diabetes
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiovascular disease
- prognostic factors
- peritoneal dialysis
- respiratory syndrome coronavirus
- cardiovascular events
- stress induced
- risk factors
- patient reported outcomes
- coronary artery disease
- glycemic control